- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 116,610 | 22.08.24 22:00:12 | +0,580 | +0,50% | 116,550 | 116,640 | 114,780 | 116,030 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 103,660 | 22.08.24 21:59:32 | -2,420 | -2,28% | 99,150 | 108,400 | 105,000 | 106,080 |
